The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Alexium gained 14.8 per cent today after receiving approval from the US Environmental Protection Agency. Approval was awarded to the company’s Alexiflam product.

Alexiflam is a patent pending flame retardant for cotton and cellulose-based textiles. The approval marks the entrance into the US consumer market for Alexiflam and will boost already present military use.

The product boasts a more environmentally friendly approach to flame retardancy. It also appeals to the market as a stronger and faster solution.

Earlier this month, Alexium also signed a distribution deal with manufacturer Israel Solutions (ICL) for Alexiflam. The deal broke barriers for Alexiflam in the global market.

Alexium CEO Bob Brookings says the ICL deal combined with the US representing the largest global market for flame retardant cotton products is a massive opportunity.

“Having delivered on these milestones, Alexium is well placed to drive the commercialization of [Alexiflam] and deliver on the global opportunities we see for our unique textile technology,” he said.

The US is reported to represent nearly half of the global flame-retardant cotton market.

Please see the announcement attached

AJX by the numbers
More From The Market Online

This stock provides Oz’s only HIV self-test kit – and it’s bullish on the budget

Atomo Diagnostics is the only company in Australia that provides TGA-approved HIV self-test kits. It says…

Recce Pharma heading closer to full efficacy data for flagship R327

Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial…
The Market Online Video

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug…

Optiscan agreement with Mayo Clinic aims to expedite robotic surgery

Optiscan Imaging is parterning with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system